$TRIV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TriVascular Technologies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TriVascular Technologies, Inc.. Get notifications about new insider transactions in TriVascular Technologies, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2016 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Sell | U | 0.00 | 3,535,910 | 0 | 0 | 3.5 M to 0 (-100.00 %) |
| Feb 05 2016 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Sell | D | 0.00 | 149 | 0 | 0 | 149 to 0 (-100.00 %) |
| Feb 05 2016 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Sell | U | 0.00 | 3,535,910 | 0 | 0 | 3.5 M to 0 (-100.00 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Thomas Robert | Option Exercise | M | 2.43 | 16,523 | 40,151 | 0 | ||
| Feb 04 2016 | TRIV | TriVascular Techno ... | Thomas Robert | Sell | D | 0.00 | 90,116 | 0 | 0 | 90.1 K to 0 (-100.00 %) | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Thomas Robert | Sell | D | 0.00 | 9,378 | 0 | 90,116 | 99.5 K to 90.1 K (-9.43 %) | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Thomas Robert | Payment of Exercise | F | 5.62 | 7,145 | 40,155 | 99,494 | 106.6 K to 99.5 K (-6.70 %) | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Thomas Robert | Buy | M | 2.43 | 16,523 | 40,151 | 106,639 | 90.1 K to 106.6 K (+18.34 %) | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Moore Daniel Jeffrey | Option Exercise | M | 2.43 | 15,661 | 38,056 | 0 | ||
| Feb 04 2016 | TRIV | TriVascular Techno ... | Moore Daniel Jeffrey | Sell | D | 0.00 | 8,889 | 0 | 0 | 8.9 K to 0 (-100.00 %) | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Moore Daniel Jeffrey | Payment of Exercise | F | 5.62 | 6,772 | 38,059 | 8,889 | 15.7 K to 8.9 K (-43.24 %) | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Moore Daniel Jeffrey | Buy | M | 2.43 | 15,661 | 38,056 | 15,661 | 0 to 15.7 K | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Option Exercise | M | 2.43 | 41,838 | 101,666 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Option Exercise | M | 0.00 | 9,400 | 0 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Sell | D | 0.00 | 23,746 | 0 | 0 | 23.7 K to 0 (-100.00 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Payment of Exercise | F | 5.62 | 18,092 | 101,677 | 23,746 | 41.8 K to 23.7 K (-43.24 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Buy | M | 2.43 | 41,838 | 101,666 | 41,838 | 0 to 41.8 K |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Sell | D | 0.00 | 5,851 | 0 | 0 | 5.9 K to 0 (-100.00 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Payment of Exercise | F | 5.62 | 3,549 | 19,945 | 5,851 | 9.4 K to 5.9 K (-37.76 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Buy | M | 0.00 | 9,400 | 0 | 9,400 | 0 to 9.4 K |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Jayaraman Vivek K | VP Global Sales and ... | Option Exercise | M | 2.43 | 47,778 | 116,101 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Jayaraman Vivek K | VP Global Sales and ... | Option Exercise | M | 0.00 | 12,400 | 0 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Jayaraman Vivek K | VP Global Sales and ... | Sell | D | 0.00 | 6,270 | 0 | 0 | 6.3 K to 0 (-100.00 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Jayaraman Vivek K | VP Global Sales and ... | Sell | D | 0.00 | 27,081 | 0 | 6,270 | 33.4 K to 6.3 K (-81.20 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Jayaraman Vivek K | VP Global Sales and ... | Payment of Exercise | F | 5.62 | 20,697 | 116,317 | 33,351 | 54 K to 33.4 K (-38.29 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Jayaraman Vivek K | VP Global Sales and ... | Buy | M | 2.43 | 47,778 | 116,101 | 54,048 | 6.3 K to 54 K (+762.01 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Jayaraman Vivek K | VP Global Sales and ... | Sell | D | 0.00 | 6,971 | 0 | 6,270 | 13.2 K to 6.3 K (-52.65 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Jayaraman Vivek K | VP Global Sales and ... | Payment of Exercise | F | 5.62 | 5,429 | 30,511 | 13,241 | 18.7 K to 13.2 K (-29.08 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Jayaraman Vivek K | VP Global Sales and ... | Buy | M | 0.00 | 12,400 | 0 | 18,670 | 6.3 K to 18.7 K (+197.77 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Elting Kimberley A. | VP, Gen. Counsel an ... | Option Exercise | M | 3.25 | 61,621 | 200,268 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Elting Kimberley A. | VP, Gen. Counsel an ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Elting Kimberley A. | VP, Gen. Counsel an ... | Sell | D | 0.00 | 4,119 | 0 | 0 | 4.1 K to 0 (-100.00 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Elting Kimberley A. | VP, Gen. Counsel an ... | Sell | D | 0.00 | 25,986 | 0 | 4,119 | 30.1 K to 4.1 K (-86.32 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Elting Kimberley A. | VP, Gen. Counsel an ... | Payment of Exercise | F | 5.62 | 35,635 | 200,269 | 30,105 | 65.7 K to 30.1 K (-54.21 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Elting Kimberley A. | VP, Gen. Counsel an ... | Buy | M | 3.25 | 61,621 | 200,268 | 65,740 | 4.1 K to 65.7 K (+1,496.02 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Elting Kimberley A. | VP, Gen. Counsel an ... | Sell | D | 0.00 | 10,102 | 0 | 4,119 | 14.2 K to 4.1 K (-71.04 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Elting Kimberley A. | VP, Gen. Counsel an ... | Payment of Exercise | F | 5.62 | 4,898 | 27,527 | 14,221 | 19.1 K to 14.2 K (-25.62 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Elting Kimberley A. | VP, Gen. Counsel an ... | Buy | M | 0.00 | 15,000 | 0 | 19,119 | 4.1 K to 19.1 K (+364.17 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chobotov Michael V. | Chief Technology Of ... | Option Exercise | M | 2.43 | 22,137 | 53,793 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chobotov Michael V. | Chief Technology Of ... | Option Exercise | M | 0.00 | 12,400 | 0 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chobotov Michael V. | Chief Technology Of ... | Sell | D | 0.00 | 174,087 | 0 | 0 | 174.1 K to 0 (-100.00 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chobotov Michael V. | Chief Technology Of ... | Sell | D | 0.00 | 7,064 | 0 | 174,087 | 181.2 K to 174.1 K (-3.90 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chobotov Michael V. | Chief Technology Of ... | Payment of Exercise | F | 5.62 | 15,073 | 84,710 | 181,151 | 196.2 K to 181.2 K (-7.68 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chobotov Michael V. | Chief Technology Of ... | Buy | M | 2.43 | 22,137 | 53,793 | 196,224 | 174.1 K to 196.2 K (+12.72 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chobotov Michael V. | Chief Technology Of ... | Sell | D | 0.00 | 6,971 | 0 | 174,087 | 181.1 K to 174.1 K (-3.85 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chobotov Michael V. | Chief Technology Of ... | Payment of Exercise | F | 5.62 | 5,429 | 30,511 | 181,058 | 186.5 K to 181.1 K (-2.91 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chobotov Michael V. | Chief Technology Of ... | Buy | M | 0.00 | 12,400 | 0 | 186,487 | 174.1 K to 186.5 K (+7.12 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chavez Christopher G. | President, CEO and ... | Option Exercise | M | 3.25 | 29,720 | 96,590 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chavez Christopher G. | President, CEO and ... | Option Exercise | M | 0.00 | 83,603 | 0 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chavez Christopher G. | President, CEO and ... | Sell | D | 0.00 | 659,952 | 0 | 0 | 660 K to 0 (-100.00 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chavez Christopher G. | President, CEO and ... | Sell | D | 0.00 | 8,441 | 0 | 659,952 | 668.4 K to 660 K (-1.26 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chavez Christopher G. | President, CEO and ... | Payment of Exercise | F | 5.62 | 21,279 | 119,588 | 668,393 | 689.7 K to 668.4 K (-3.09 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chavez Christopher G. | President, CEO and ... | Buy | M | 3.25 | 29,720 | 96,590 | 689,672 | 660 K to 689.7 K (+4.50 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chavez Christopher G. | President, CEO and ... | Sell | D | 0.00 | 60,168 | 0 | 659,952 | 720.1 K to 660 K (-8.36 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chavez Christopher G. | President, CEO and ... | Payment of Exercise | F | 5.62 | 23,435 | 131,705 | 720,120 | 743.6 K to 720.1 K (-3.15 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Chavez Christopher G. | President, CEO and ... | Buy | M | 0.00 | 83,603 | 0 | 743,555 | 660 K to 743.6 K (+12.67 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Kramer Michael R | Chief Financial Off ... | Option Exercise | M | 2.43 | 16,032 | 38,958 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Kramer Michael R | Chief Financial Off ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Kramer Michael R | Chief Financial Off ... | Sell | D | 0.00 | 92,309 | 0 | 0 | 92.3 K to 0 (-100.00 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Kramer Michael R | Chief Financial Off ... | Sell | D | 0.00 | 8,794 | 0 | 92,309 | 101.1 K to 92.3 K (-8.70 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Kramer Michael R | Chief Financial Off ... | Payment of Exercise | F | 5.62 | 7,238 | 40,678 | 101,103 | 108.3 K to 101.1 K (-6.68 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Kramer Michael R | Chief Financial Off ... | Buy | M | 2.43 | 16,032 | 38,958 | 108,341 | 92.3 K to 108.3 K (+17.37 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Kramer Michael R | Chief Financial Off ... | Sell | D | 0.00 | 8,439 | 0 | 92,309 | 100.7 K to 92.3 K (-8.38 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Kramer Michael R | Chief Financial Off ... | Payment of Exercise | F | 5.62 | 6,561 | 36,873 | 100,748 | 107.3 K to 100.7 K (-6.11 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Kramer Michael R | Chief Financial Off ... | Buy | M | 0.00 | 15,000 | 0 | 107,309 | 92.3 K to 107.3 K (+16.25 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Sell | D | 0.00 | 3,943,269 | 0 | 0 | 3.9 M to 0 (-100.00 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | Scopa James Paul | Director | Sell | D | 0.00 | 1,776,692 | 0 | 0 | 1.8 M to 0 (-100.00 %) |
| May 27 2015 | TRIV | TriVascular Techno ... | Moore Daniel Jeffrey | Option Exercise | A | 5.85 | 10,000 | 58,500 | 10,000 | ||
| May 27 2015 | TRIV | TriVascular Techno ... | Scopa James Paul | Option Exercise | A | 5.85 | 10,000 | 58,500 | 10,000 | ||
| May 27 2015 | TRIV | TriVascular Techno ... | Thomas Robert | Option Exercise | A | 5.85 | 10,000 | 58,500 | 10,000 | ||
| May 27 2015 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Option Exercise | A | 5.85 | 10,000 | 58,500 | 10,000 | ||
| May 27 2015 | TRIV | TriVascular Techno ... | Nunn Jason Raleigh | Director | Option Exercise | A | 5.85 | 10,000 | 58,500 | 10,000 | |
| May 27 2015 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | A | 5.85 | 10,000 | 58,500 | 10,000 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Elting Kimberley A. | VP, Gen. Counsel an ... | Option Exercise | A | 10.94 | 28,400 | 310,696 | 28,400 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Elting Kimberley A. | VP, Gen. Counsel an ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Chavez Christopher G. | President, CEO and ... | Option Exercise | A | 10.94 | 85,100 | 930,994 | 85,100 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Chavez Christopher G. | President, CEO and ... | Option Exercise | A | 0.00 | 38,503 | 0 | 38,503 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Chavez Christopher G. | President, CEO and ... | Option Exercise | A | 0.00 | 45,100 | 0 | 45,100 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Kramer Michael R | Chief Financial Off ... | Option Exercise | A | 10.94 | 28,400 | 310,696 | 28,400 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Kramer Michael R | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Option Exercise | A | 10.94 | 17,700 | 193,638 | 17,700 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Option Exercise | A | 0.00 | 9,400 | 0 | 9,400 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Molinari Louis J. | VP Manufacturing Op ... | Option Exercise | A | 10.94 | 17,700 | 193,638 | 17,700 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Molinari Louis J. | VP Manufacturing Op ... | Option Exercise | A | 0.00 | 9,400 | 0 | 9,400 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Whirley Robert G | VP Research and Dev ... | Option Exercise | A | 10.94 | 17,700 | 193,638 | 17,700 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Whirley Robert G | VP Research and Dev ... | Option Exercise | A | 0.00 | 9,400 | 0 | 9,400 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Chobotov Michael V. | Chief Technology Of ... | Option Exercise | A | 10.94 | 23,400 | 255,996 | 23,400 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Chobotov Michael V. | Chief Technology Of ... | Option Exercise | A | 0.00 | 12,400 | 0 | 12,400 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Jayaraman Vivek K | VP Global Sales and ... | Option Exercise | A | 10.94 | 23,400 | 255,996 | 23,400 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | Jayaraman Vivek K | VP Global Sales and ... | Option Exercise | A | 0.00 | 12,400 | 0 | 12,400 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 15.81 | 55,831 | 882,470 | 55,831 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 0.00 | 55,831 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 0.00 | 411,234 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | A | 0.00 | 411,234 | 0 | 411,234 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 0.00 | 1,236,487 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 0.00 | 531,758 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 0.00 | 383,249 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Option Exercise | C | 0.00 | 797,208 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Buy | C | 0.00 | 411,234 | 0 | 3,943,269 | 3.5 M to 3.9 M (+11.64 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Buy | C | 0.00 | 1,236,487 | 0 | 3,532,035 | 2.3 M to 3.5 M (+53.86 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Buy | C | 0.00 | 531,758 | 0 | 2,295,548 | 1.8 M to 2.3 M (+30.15 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Buy | C | 0.00 | 383,249 | 0 | 1,763,790 | 1.4 M to 1.8 M (+27.76 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Buy | C | 0.00 | 797,208 | 0 | 1,380,541 | 583.3 K to 1.4 M (+136.66 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | DRANT RYAN D | Director | Buy | P | 12.00 | 583,333 | 6,999,996 | 583,333 | 0 to 583.3 K |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 15.81 | 55,831 | 882,470 | 55,831 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 55,831 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 411,234 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 1,236,487 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 531,758 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 383,249 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Option Exercise | C | 0.00 | 797,208 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Buy | C | 0.00 | 411,234 | 0 | 3,943,269 | 3.5 M to 3.9 M (+11.64 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Buy | C | 0.00 | 1,236,487 | 0 | 3,532,035 | 2.3 M to 3.5 M (+53.86 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Buy | C | 0.00 | 531,758 | 0 | 2,295,548 | 1.8 M to 2.3 M (+30.15 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Buy | C | 0.00 | 383,249 | 0 | 1,763,790 | 1.4 M to 1.8 M (+27.76 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Buy | C | 0.00 | 797,208 | 0 | 1,380,541 | 583.3 K to 1.4 M (+136.66 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | New Enterprise Associates 12, ... | 10% Owner | Buy | P | 12.00 | 583,333 | 6,999,996 | 583,333 | 0 to 583.3 K |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | A | 8.93 | 4,929 | 44,016 | 4,929 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | C | 15.81 | 6,326 | 99,989 | 6,326 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | C | 0.00 | 6,326 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | C | 0.00 | 7,847 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | A | 0.00 | 7,847 | 0 | 7,847 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | C | 0.00 | 41,453 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | C | 0.00 | 17,725 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Option Exercise | C | 0.00 | 11,537 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Buy | C | 0.00 | 7,847 | 0 | 86,838 | 79 K to 86.8 K (+9.93 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Buy | C | 0.00 | 41,453 | 0 | 78,991 | 37.5 K to 79 K (+110.43 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Buy | C | 0.00 | 17,725 | 0 | 37,538 | 19.8 K to 37.5 K (+89.46 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Thomas Robert | Director | Buy | C | 0.00 | 11,537 | 0 | 19,813 | 8.3 K to 19.8 K (+139.40 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 15.81 | 45,094 | 712,760 | 45,094 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 0.00 | 45,094 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 0.00 | 347,965 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | A | 0.00 | 347,965 | 0 | 347,965 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 0.00 | 970,167 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 0.00 | 424,918 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 0.00 | 384,594 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Option Exercise | C | 0.00 | 574,933 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Buy | C | 0.00 | 347,965 | 0 | 3,535,910 | 3.2 M to 3.5 M (+10.92 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Buy | C | 0.00 | 970,167 | 0 | 3,187,945 | 2.2 M to 3.2 M (+43.75 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Buy | C | 0.00 | 424,918 | 0 | 2,217,778 | 1.8 M to 2.2 M (+23.70 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Buy | C | 0.00 | 384,594 | 0 | 1,792,860 | 1.4 M to 1.8 M (+27.31 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Buy | C | 0.00 | 574,933 | 0 | 1,408,266 | 833.3 K to 1.4 M (+68.99 %) |
| Apr 24 2014 | TRIV | TriVascular Techno ... | ROEDER DOUGLAS A | Director | Buy | P | 12.00 | 833,333 | 9,999,996 | 833,333 | 0 to 833.3 K |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 15.81 | 45,094 | 712,760 | 45,094 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 45,094 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 347,965 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | A | 0.00 | 347,965 | 0 | 347,965 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 970,167 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 424,918 | 0 | 0 | |
| Apr 24 2014 | TRIV | TriVascular Techno ... | Delphi Management Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 384,594 | 0 | 0 |